Global Neurology Academy - Global Neurology Academy

Global Neurology Academy

Global Neurology Academy

Enhance your practice with CME
and tools that focus on the management
of neurological conditions.

Popular

Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
CME/CE
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
0.25 credits
- Dani Cabral, MD
0.25 credits
Recognizing the Signs of TK2 Deficiency
Recognizing the Signs of TK2 Deficiency
NeuroFrontiers
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
- Kaitlin Batley, MD
Uncovering TK2d: How to Navigate Diagnostic Challenges
Uncovering TK2d: How to Navigate Diagnostic Challenges
NeuroFrontiers
Uncovering TK2d: How to Navigate Diagnostic Challenges
Kaitlin Batley, MD
- Kaitlin Batley, MD
A Closer Look at the Biology Behind MS Progression
A Closer Look at the Biology Behind MS Progression
NeuroFrontiers
A Closer Look at the Biology Behind MS Progression
Ethan Meltzer, MD
- Ethan Meltzer, MD
Implementing Cognitive Screening in MS Care
Implementing Cognitive Screening in MS Care
NeuroFrontiers
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
- Elizabeth S. Gromisch, PhD
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
CME/CE
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS; Valeria Caso, MD, PhD
0.75 credits
- C. Michael Gibson, MD, MS
- Valeria Caso, MD, PhD
- Ashkan Shoamanesh, MD
0.75 credits
The New Era of Targeted Therapy for Myasthenia Gravis
The New Era of Targeted Therapy for Myasthenia Gravis
NeuroFrontiers
The New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
- Shruti Raja, MD, MHS
Immunologic Phenotyping: The Future of Personalized MG Care
Immunologic Phenotyping: The Future of Personalized MG Care
NeuroFrontiers
Immunologic Phenotyping: The Future of Personalized MG Care
Shruti Raja, MD, MHS
- Shruti Raja, MD, MHS

Medical News

Medical News
Stroke-Associated Pneumonia Clusters Early After Ischemic Stroke
11/13/2026
Read more
Medical News
ED Amnesia Testing After Head Injury: 8.2% Failed A-WPTAS
11/12/2026
Read more
Medical News
Bayer Reports Asundexian Approval for Secondary Stroke Prevention
11/10/2026
Read more
Medical News
Pontine Infarct Imaging Phenotypes Linked to Early Deterioration
11/06/2026
Read more

CME/CE

When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
CME/CE Broadcast Replay
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
Dani Cabral, MD; David Weisman, MD
1.00 credit
- Dani Cabral, MD
- David Weisman, MD
1.00 credit
Navigating the Limitations of Current BD Therapies
Navigating the Limitations of Current BD Therapies
MinuteCE®
Navigating the Limitations of Current BD Therapies
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
MinuteCE®
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
MinuteCE®
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits

Clinical Practice

Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
NeuroFrontiers
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Kaitlin Batley, MD
- Kaitlin Batley, MD
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
NeuroFrontiers
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Ethan Meltzer, MD
- Ethan Meltzer, MD
Navigating Emerging Biomarkers in MS Care
Navigating Emerging Biomarkers in MS Care
NeuroFrontiers
Navigating Emerging Biomarkers in MS Care
Ethan Meltzer, MD
- Ethan Meltzer, MD
Precision Medicine for Myasthenia Gravis
Precision Medicine for Myasthenia Gravis
NeuroFrontiers
Precision Medicine for Myasthenia Gravis
Shruti Raja, MD, MHS
- Shruti Raja, MD, MHS

Programs

Discharge Planning After Myasthenic Crisis
Discharge Planning After Myasthenic Crisis
NeuroFrontiers
Discharge Planning After Myasthenic Crisis
Qihua Fan, MD
- Qihua Fan, MD
Navigating Emerging Treatment Options in MG
Navigating Emerging Treatment Options in MG
NeuroFrontiers
Navigating Emerging Treatment Options in MG
Qihua Fan, MD
- Qihua Fan, MD
More Than a Myopathy: The Lived Experience of TK2d
More Than a Myopathy: The Lived Experience of TK2d
NeuroFrontiers
More Than a Myopathy: The Lived Experience of TK2d
Outcome Measures Capture Progression in Late-Onset TK2d
Outcome Measures Capture Progression in Late-Onset TK2d
NeuroFrontiers
Outcome Measures Capture Progression in Late-Onset TK2d